Aakaar Medical Technologies Board of Directors
Get the latest insights into the leadership at Aakaar Medical Technologies. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Ms. Bindi Dilip Meswani | Chairperson & Non Executive Director |
| Mr. Dilip Ramesh Meswani | Managing Director |
| Mr. Rahul Babasaheb Sawakhande | Executive Director & CEO |
| Mr. Deepanjan Periwal | Independent Director |
| Mr. Rajendra Indubhai Dhandhukia | Independent Director |
Aakaar Medical Technologies Share price
AAKAAR
85
1.00 (-1.16%)Last updated on 4 Nov, 2025 | 10:58 IST
BUYSELL
Today's High
85.00
Today's Low
85.00
52 Week Low
62.00
52 Week High
105.00
The current prices are delayed, login to your account for live prices
LoginAakaar Medical Technologies FAQs
The board at Aakaar Medical Technologies consists of experienced professionals, including Ms. Bindi Dilip Meswani , Mr. Dilip Ramesh Meswani , and others, overseeing the company’s strategic and corporate governance.
Directors at Aakaar Medical Technologies are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Ms. Bindi Dilip Meswani is the current chairman at Aakaar Medical Technologies.
Executive directors at Aakaar Medical Technologies are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Aakaar Medical Technologies adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Aakaar Medical Technologies, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.